Zhejiang Huahai Pharmaceutical Co., Ltd.
600521
Classement en actions
#4339
Zhejiang Huahai Pharmaceutical Co., Ltd. is a China-based pharmaceutical... Zhejiang Huahai Pharmaceutical Co., Ltd. is a China-based pharmaceutical enterprise with a global presence. Its diverse portfolio encompasses treatments for central nervous system disorders, cardiovascular conditions, and viral infections, among other finished pharmaceutical products. Beyond finished drugs, the company also produces Active Pharmaceutical Ingredients (APIs) and crucial intermediates. Huahai Pharmaceutical further engages in the manufacturing of packaging components, notably high-density polyethylene (HDPE) bottles and polypropylene (PP) caps. Additionally, it offers contract manufacturing (CMO) and other specialized services, while also playing a role in import and export trade services. Established in 1989, the company maintains its headquarters in Linhai, China.
Prix de l'action
$2.42
Capitalisation boursière
$3.62B
Changement (1 jour)
-0.24%
Changement (1 an)
-10.04%
Pays
CN
Échange Zhejiang Huahai Pharmaceutical Co., Ltd. (600521)
Catégorie
Healthcare
Bénéfices pour Zhejiang Huahai Pharmaceutical Co., Ltd. (600521)
Bénéfices en Jun 2026 TTM : $116.37M
Selon les derniers rapports financiers de Zhejiang Huahai Pharmaceutical Co., Ltd., les bénéfices actuels de l'entreprise sont de $116.37M. En 2023, l'entreprise a réalisé un bénéfice de $155.44M, une diminution par rapport à celui de 2022 qui était de $218.75M. Les bénéfices affichés sur cette page correspondent aux bénéfices avant intérêts et impôts, appelés aussi EBIT.
Historique des bénéfices pour Zhejiang Huahai Pharmaceutical Co., Ltd. de 2000 à 2026
Bénéfices à la fin de chaque année
| Année | Bénéfices | Changez |
|---|---|---|
| 2026 (TTM) | $116.37M | -41.96% |
| 2024 | $200.52M | 29.00% |
| 2023 | $155.44M | -28.94% |
| 2022 | $218.75M | 76.68% |
| 2021 | $123.81M | -33.45% |
| 2020 | $186.04M | 70.26% |
| 2019 | $109.27M | 378.00% |
| 2018 | $22.86M | -80.91% |
| 2017 | $119.77M | 46.64% |
| 2016 | $81.68M | 1.26% |
| 2015 | $80.66M | 59.65% |
| 2014 | $50.52M | -25.67% |
| 2013 | $67.97M | 5.47% |
| 2012 | $64.44M | 48.73% |
| 2011 | $43.33M | 123.78% |
| 2010 | $19.36M | -32.37% |
| 2009 | $28.63M | 16.51% |
| 2008 | $24.57M | -5.07% |
| 2007 | $25.88M | 35.84% |
| 2006 | $19.05M | -12.70% |
| 2005 | $21.83M | 10.70% |
| 2004 | $19.72M | 36.00% |
| 2003 | $14.50M | 63.58% |
| 2002 | $8.86M | 36.52% |
| 2001 | $6.49M | 2.99% |
| 2000 | $6.30M | 0.00% |
Bénéfices des entreprises similaires ou concurrentes
| Entreprise | Bénéfices | Différence de bénéfices | Pays |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $1.76B | 1,416.29% |
IN
|
